NCT04383002View on ClinicalTrials.gov

High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

May 11, 2021

Study Completion Date

June 11, 2021

Conditions
COVID-19
Interventions
DRUG

Nitric Oxide

iNO will be given at 160ppm for 6 hours, once a day, for 2 days

Trial Locations (1)

M5G 2C4

University Health Network, Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT04383002 - High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) | Biotech Hunter | Biotech Hunter